Biogen, a global biotechnology company headquartered in Weston, MA, is dedicated to pioneering innovative solutions for a range of diseases such as Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis. With a strong focus on science and innovation, Biogen is committed to developing transformative medicines through research, clinical trials, and early access programs. The company places a strong emphasis on corporate responsibility, promoting access and health equity, diversity, equity, and inclusion, as well as environmental sustainability. Biogen's mission is to make a difference and change lives through groundbreaking advancements in healthcare.